MACROGENICS, INC. Fair Value Adjustment of Warrants
MACROGENICS, INC. (MGNX) reported Fair Value Adjustment of Warrants of $0 for the 12-month period ending 2015-12-31, per its 10-K filed 2016-02-29.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2016-02-29
- MACROGENICS, INC. fair value adjustment of warrants for the quarter ending 2013-12-31 was $0.00.
- MACROGENICS, INC. fair value adjustment of warrants for the quarter ending 2013-09-30 was $554.00K.
- MACROGENICS, INC. fair value adjustment of warrants for the quarter ending 2013-06-30 was $41.45K.
- MACROGENICS, INC. fair value adjustment of warrants for the quarter ending 2013-03-31 was $30.55K.
- MACROGENICS, INC. fair value adjustment of warrants for fiscal 2015 was $0.00.
- MACROGENICS, INC. fair value adjustment of warrants for fiscal 2014 was $0.00, a 100.00% decline from fiscal 2013.
- MACROGENICS, INC. fair value adjustment of warrants for fiscal 2013 was $626.00K.
- MACROGENICS, INC. fair value adjustment of warrants for fiscal 2012 was -$151.00K.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 9 month as first filed | Fair Value Adjustment of Warrants 12 month | Fair Value Adjustment of Warrants 12 month as first filed |
|---|---|---|---|---|---|---|
| 2015-12-31 | $0.00 10-K · filed 2016-02-29 | |||||
| 2014-12-31 | $0.00 10-K · filed 2016-02-29 | |||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $554.00K derived: sum of 2 quarters · filed 2016-02-29 | $595.45K derived: sum of 3 quarters · filed 2016-02-29 | $626.00K 10-K · filed 2016-02-29 | $626.35K 10-K · filed 2014-03-20 | |
| 2013-09-30 | $554.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $595.45K derived: sum of 2 quarters · filed 2014-11-12 | $626.00K 10-Q · filed 2014-11-12 | $626.35K 10-Q · filed 2013-11-12 | ||
| 2013-06-30 | $41.45K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $72.00K 10-Q · filed 2014-08-05 | ||||
| 2013-03-31 | $30.55K 10-Q · filed 2014-05-06 | |||||
| 2012-12-31 | -$151.00K 10-K · filed 2015-03-03 | -$150.69K 10-K · filed 2014-03-20 | ||||
| 2011-12-31 | -$1.46M 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |